Why Patients Switch Between These Weight Loss Treatments
Difference Between Wegovy and Mounjaro UK: Mechanism Comparison
The fundamental difference between Wegovy and Mounjaro UK lies in their active ingredients and mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural fullness hormone your body produces after eating. This single-action approach has proven highly effective in clinical trials. Mounjaro, containing tirzepatide, works differently as a dual agonist targeting both GIP and GLP-1 receptors simultaneously. Both are prescription-only medicines requiring clinical assessment and work alongside a reduced-calorie diet and increased physical activity.
When considering the difference between Wegovy and Mounjaro UK for switching treatments, patients often find that individual response varies significantly. Some respond better to Wegovy's targeted GLP-1 action, while others prefer Mounjaro's dual mechanism. Your prescriber can guide you through the transition process, ensuring safe dose conversion if switching between treatments. EverydayMeds stocks both medications, making any transition seamless through our GPhC-registered pharmacy service.
Wegovy vs Mounjaro UK Pricing: Complete Cost Comparison
Understanding the pricing difference between Wegovy and Mounjaro UK helps inform switching decisions. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Bundle options provide convenient multi-month supply: the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Duo (0.5mg & 1mg) is £189.99. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 for additional savings.
The cost difference between Wegovy and Mounjaro UK often influences switching decisions, particularly for long-term treatment. Wegovy's transparent pricing structure allows for better budgeting throughout the dose escalation phase. Bundle options like the Ultimate Stability Trio (three 2.4mg pens for £649.99) provide three months of maintenance supply convenience. When comparing ongoing costs, factor in your target maintenance dose and consider bundle savings for consistent supply without repeated ordering.
Clinical Evidence: Difference Between Wegovy and Mounjaro UK Trials
The clinical difference between Wegovy and Mounjaro UK becomes apparent through their respective trial programmes. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different patient populations, including those with type 2 diabetes and cardiovascular risk factors.
Mounjaro's clinical programme used different trial designs and patient populations, making direct comparison inappropriate. However, both treatments have demonstrated significant efficacy when used as prescribed. The SELECT cardiovascular outcomes trial showed Wegovy reduced major cardiovascular events by 20%, adding an important safety dimension to treatment selection. Your prescriber can discuss which clinical profile may be more suitable for your individual circumstances.
How Wegovy Works: Understanding the Difference Between Wegovy and Mounjaro UK
Wegovy works as a GLP-1 receptor agonist, meaning it activates the same receptors as glucagon-like peptide-1, a hormone naturally released by your intestines after eating. This activation sends fullness signals to your brain, reducing appetite and helping you feel satisfied with smaller portions. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Unlike Mounjaro's dual action, Wegovy focuses specifically on GLP-1 pathways, which may suit patients who respond well to this targeted approach. The once-weekly injection using the FlexTouch pen provides consistent medication levels throughout the week, supporting steady appetite regulation.
Switching Process: Ordering Through EverydayMeds
Switching between treatments through EverydayMeds follows our streamlined three-step process, whether you're moving from Mounjaro to Wegovy or starting fresh. Begin with our 3-minute online clinical assessment, providing details about your current treatment, medical history, and reasons for switching. Our prescribing team reviews your assessment within three working days (or 24 hours with express service), considering dose conversion requirements and any washout period needed. Once approved, your Wegovy prescription is dispatched via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all medications meet strict UK quality standards.
Storage and Practical Differences: Wegovy vs Mounjaro UK
A practical difference between Wegovy and Mounjaro UK involves storage flexibility, which matters for patients with active lifestyles. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy more suitable for extended travel or situations where refrigeration isn't consistently available. Both use pre-filled injection pens, but Wegovy's FlexTouch system offers dose confirmation through an audible click and visual indicators. The dose escalation schedule differs slightly between treatments, with Wegovy following a structured 4-week progression through each strength before reaching the 2.4mg maintenance dose.
Why Patients Switch: Key Difference Between Wegovy and Mounjaro UK Considerations
The most common reasons for switching highlight the difference between Wegovy and Mounjaro UK in real-world use. Cost considerations often drive switches, particularly when patients reach maintenance dosing and need consistent long-term supply. Side effect profiles may vary between individuals, with some tolerating one medication better than the other despite similar mechanisms. Wegovy's longer room temperature storage provides practical advantages for frequent travelers or those with refrigeration concerns.
Availability and prescription consistency also influence switching decisions, as patients prefer reliable supply chains for long-term treatment. Some patients switch based on injection frequency preferences or pen design comfort, while others make decisions based on their prescriber's familiarity with specific treatments. EverydayMeds supports both medications, allowing seamless transitions without changing pharmacy providers or learning new ordering systems.
Making Your Switch: Complete Difference Between Wegovy and Mounjaro UK Decision
Deciding between these treatments involves weighing the difference between Wegovy and Mounjaro UK across multiple factors beyond just efficacy. Consider your budget for long-term treatment, storage requirements, travel frequency, and any previous experience with GLP-1 medications. Wegovy's proven cardiovascular benefits may influence decisions for patients with heart disease risk factors, while others prioritize cost-effectiveness and storage flexibility. Your prescriber will guide dose conversion if switching from another GLP-1 medication, ensuring safe transition protocols.
Both treatments require commitment to lifestyle changes including reduced-calorie diet and increased physical activity for optimal results. The difference between Wegovy and Mounjaro UK may be less important than consistency with whichever treatment you choose long-term. EverydayMeds provides ongoing support throughout your treatment journey, whether you're switching medications or starting your first prescription. Our clinical team remains available for questions about side effects, dose progression, or treatment optimization.
Ready to explore your options? Visit our weight loss collection to begin your clinical assessment. New customers can use code FIRST40 at checkout, while returning customers apply DOSE25 for additional savings. Our GPhC-registered service (#9012878) ensures safe, legal access to these prescription-only medicines with full prescriber oversight and next-day delivery support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
